May 7, 2021 This Week in Cardiology Podcast

May 7, 2021 This Week in Cardiology Podcast

COVID-19 and BMI, TAVR vs SAVR, subcutaneous ICD, SGLT2 inhibitors, and physician-Moms are the topics John Mandrola, MD, discusses in this week's podcast. https://www.medscape.com/twic

COVID-19

COVID-19 Severity Starts in Normal BMI Range, Especially in Young https://www.medscape.com/viewarticle/950568

- Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00089-9/fulltext

TAVR vs SAVR

VARC-3 Sets Goalpost for Future Aortic Valve Trials https://www.medscape.com/viewarticle/950012

- Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaa799/6237954

TAVR Availability

Patchy Growth of TAVR Programs Leaves Poorer Communities Behind https://www.medscape.com/viewarticle/950316

S-ICD

Trade-offs Between Subcutaneous, Transvenous ICDs on Display in EFFORTLESS https://www.medscape.com/viewarticle/950328

- Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study https://doi.org/10.1016/j.jacc.2017.06.040

- Reduction in Inappropriate Therapy and Mortality through ICD Programming https://www.nejm.org/doi/full/10.1056/NEJMoa1211107

- Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results https://doi.org/10.1016/j.hrthm.2015.01.017

Dapagliflozin and CKD

FDA Approves Dapagliflozin (Farxiga) for Chronic Kidney Disease https://www.medscape.com/viewarticle/950329

Features

New Physician Moms Need More Resources and Less Guilt in the Workplace https://www.medscape.com/viewarticle/949765

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Episoder(397)

Jan 24 2025 This Week in Cardiology

Jan 24 2025 This Week in Cardiology

Familial hypercholesterolemia, cardiac arrest therapy, Factor XI inhibition, and tricuspid valve interventions are the topics John Mandroa, MD, discusses in this week's podcast. This podcast is intend...

24 Jan 202525min

Jan 17 2025 This Week in Cardiology

Jan 17 2025 This Week in Cardiology

Renal denervation, the obesity paradox, JACC and the FINEARTS trial of finerenone in HFpEF, a setback for a PFA system, and coffee are the topics Jon Mandrola, MD, covers this week. This podcast is in...

17 Jan 202531min

Jan 10 2025 This Week in Cardiology

Jan 10 2025 This Week in Cardiology

Alcohol and cancer, GLP-1 trial representativeness, diagnosing CAD, changing stroke rates in patients with AF, blanking periods after AF ablation are the topics John Mandrola, MD, covers this week. Th...

10 Jan 202530min

Dec 20 2024 This Week in Cardiology

Dec 20 2024 This Week in Cardiology

Listener feedback, multiple studies in AF ablation, a DANISH trial substudy of ICDs in NICM, and more data on eye complications of GLP-1 agonists are the topics John Mandrola, MD, covers in this week'...

20 Des 202436min

Dec 13 2024 This Week in Cardiology

Dec 13 2024 This Week in Cardiology

US doc's pay, the ticagrelor controversy and new RCTs, clopidogrel beats ASA, holding antiplatelets for non-cardiac surgery, and Prof Cleland and ASA dogma are the topics John Mandrola, MD, covers thi...

13 Des 202429min

Dec 06 2024 This Week in Cardiology

Dec 06 2024 This Week in Cardiology

Tirzepatide vs semaglutide in obesity; GLP1a use is complicated; HF outcomes; the misuse of meta-analyses in HF; and a breakthrough in HF care are the topics John Mandrola, MD, covers this week. This ...

6 Des 202427min

Nov 22 2024 This Week in Cardiology

Nov 22 2024 This Week in Cardiology

An AHA review: the OPTION, SUMMIT, VANISH 2, SARAH, and CLEAR trials are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To ...

22 Nov 202432min

Nov 15 2024 This Week in Cardiology

Nov 15 2024 This Week in Cardiology

Tirzepatide, AF screening, and an AHA preview, including VT ablation, LAAC at the time of AF ablation, BP targets, and GLP1 agonists in HF are the topics John Mandrola, MD, covers in today's podcast. ...

15 Nov 202428min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rekommandert
liberal-halvtime
sinnsyn
rss-nysgjerrige-norge
forskningno
rss-rekommandert
fjellsportpodden
smart-forklart
vett-og-vitenskap-med-gaute-einevoll
jss
villmarksliv
rss-overskuddsliv
kvinnehelsepodden
rss-radium
rss-inn-til-kjernen-med-sunniva-rose
nordnorsk-historie
nevropodden
hva-er-greia-med